Pfizer Inc. (NYSE: PFE) is scheduled to report its fourth-quarter financial results before the markets open on Tuesday. The consensus estimates from Thomson Reuters are $0.52 in earnings per share (EPS) on $13.57 billion in revenue. In the same period of the previous year, Pfizer posted EPS of $0.54 and $13.11 billion in revenue.
Be advised that the earnings and revenue estimates may change ahead of the formal reports.
This stock could be offering investors a great value at current trading levels. Pfizer rocked Wall Street last year by announcing a gigantic $15.2 billion purchase of Hospira, a top provider of sterile injectable drugs — including those used for acute care and cancer treatment — infusion technologies and biosimilars, which are subsequent versions of drugs whose patents have expired.
With a strong pipeline and the fact that Pfizer is the world’s largest drug manufacturer by sales volume, many analysts feel the company can generate higher long-term revenues through the accelerated growth of its new drugs over the next five years, with Ibrance leading the way. Some on Wall Street also predict that the company will make an accretive acquisition between now and the end of 2016.
24/7 Wall St.Sales of Ibrance totaled more than $250 million in the firm’s most recent quarterly earnings report. The pill, which essentially doubled the survival rate for certain advanced breast cancer patients, is already being widely prescribed.
In the most recent settlement date, Pfizer saw its short interest remain relatively flat at 123.23 million shares, relative to the previous 123.45 million. The highest short interest reading over the past year was 207.4 million.
So far in 2016, Pfizer is more or less in line with the broad markets, with the stock is down about 5.6% year to date. Over the past 52 weeks, the stock is down only 1%.
Shares of Pfizer were trading at $29.90 on Monday, with a consensus analyst price target of $40.19 and a 52-week trading range of $28.47 to $36.46.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
